Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice

This publication has 52 references indexed in Scilit:

• Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice†
  Hepatology, 2007
• Relationship Among Histologic, Radiologic, and Biochemical Assessments of Hepatic Steatosis
  Journal of Clinical Gastroenterology, 2007
• Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways
  Journal of Lipid Research, 2006
• Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
  Biochemical and Biophysical Research Communications, 2004
• Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by Srebp–1 Suppression
  Hepatology, 2003
• Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial.
  Journal of the American College of Nutrition, 1997
• Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Raised hepatic free fatty acids in a patient with acute fatty liver after gastric surgery for morbid obesity.
  Journal of Clinical Pathology, 1986
• The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
  New England Journal of Medicine, 1985
• Fatty acid composition of adipose tissue, blood lipids, and glucose tolerance in patients with different degrees of angiographically documented coronary arteriosclerosis
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1982